Shorts

0:59
Can GLP-1 drugs lower cancer risk?
2 days ago
by
Jennifer Ligibel, MD

0:55
Neoantigen Vaccines Signal A New Arm of Cancer Immunotherapy
3 days ago
by
Karen E. Knudsen, MBA, PHD

0:31
RWD: Closing Gaps in Guideline-Based Oncology Care
4 days ago
by
Ravi Parikh, MD, MPP

0:32
KRAS G12D Inhibitor Combos Advance in Pancreatic Cancer
9 days ago
by
Shubham Pant, MD, MBBS

0:46
Encouraging Healthy Weight Loss in Patients With Cancer
10 days ago
by
Sai Yendamuri, MD, MBA, FACS

0:57
Why Explore Vaccines After Pancreatic Cancer Surgery?
11 days ago
by
Shubham Pant, MD, MBBS

0:17
Is the future of pancreatic cancer finally shifting away from chemotherapy?
13 days ago
by
Zev A. Wainberg, MD

1:11
Pancreatic Cancer Vaccine Findings Warrant Further Study
15 days ago
by
Shubham Pant, MD, MBBS

0:49
Is liquid biopsy the game-changer for lung cancer treatment?
16 days ago
by
Valsamo Anagnostou, MD, PhD

0:41
The Future of Colorectal Cancer Treatment: Refining Patient Selection
19 days ago
by
Sara Lonardi, MD

1:18
Breakthrough Cancer Vaccine Reduces Melanoma Recurrence by 42%
20 days ago
by
Georgina Long, BSc, PhD, MBBS, FRACP

0:44
Offering a Chemotherapy-Free Option in Endometrial Cancer
22 days ago
by
Brian Slomovitz, MD, MS, FACOG

0:34
When to Consider Dual Immunotherapy in NSCLC
a month ago
by
Matthew A. Gubens, MD, MS

1:13
Key Findings from the Real-World ARAAT Trial
a month ago
by
Alicia K. Morgans, MD, MPH

1:05
Using Chemo Before Targeted Therapy in NSCLC?
a month ago
by
Lyudmila Bazhenova, MD

0:32
The Switch from IV to Subcutaneous Drug Delivery
a month ago
by
J. Thaddeus Beck, MD

0:50
Telehealth Brings Myeloma Expertise Closer to Home
a month ago
by
Ashley Rosko, MD

0:39
Stop Assuming, Start Asking: Understanding the 'No'
a month ago
by
Narjust Florez, MD

0:43
Don’t Wait Until the Last Line to Consider Clinical Trials
a month ago
by
Krish Patel, MD

0:47
Unlocking New Possibilities in Metastatic Breast Cancer Treatment
a month ago
by
Komal Jhaveri, MD, FACP

0:30
Strategies for Sequencing Therapies in RCC
a month ago
by
Daniel Heng, MD

0:46
CLL Outcomes Are Closing in on Age-Matched Controls
a month ago
by
Jeff Sharman, MD

0:57
FDA Approval on the Horizon for Anito-cel in Multiple Myeloma
2 months ago
by
Matthew J. Frigault, MD, MS

1:00
Trispecifics Take T-Cell–Engaging Therapy a Step Further
2 months ago
by
Krish Patel, MD

0:37
Are KRAS Mutations More Common Than We Think?
2 months ago
by
Benjamin Herzberg, MD

0:15
2026 IMS Annual Meeting Highlights Across Myeloma
2 months ago

0:54
ASTRO 2026 Preview with Dr Raj Singh
2 months ago
by
Raj Singh, MD

0:35
Changing Treatment Paradigms in ROS1+ Lung Cancer
2 months ago
by
Jorge Nieva, MD

0:53
Why Community Cancer Centers Must Adapt to New Therapies
2 months ago
by
Andrew Dalovisio, MD

0:55
Why Radiation Therapy Hits a Wall
2 months ago
by
David DiBardino, MD
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
2
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
3
FDA Approves Giredestrant Plus Everolimus in ESR1-Mutated Breast Cancer
4
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
5
